BiorLabs
BYB
Evaluation Score
Overall rating on a scale of 0-10
Dimension Breakdown
AI Analysis
Comprehensive evaluation of the token
BYB (BiorLabs, formerly BiorBank) is an early-stage micro-cap ERC-20 token operating in the competitive portfolio-tracking space. The project scores poorly across all evaluated categories: Active Development is limited (3.0/10) with unverified engineering activity; Community Support is critically low (1.0/10) with only ~607 holders and virtually no organic social or governance presence; Market and Use Case (2.0/10) is hampered by extreme illiquidity, near-zero volume, and lack of a competitive moat; and Team and Governance (2.5/10) lacks any identified leadership or established governance mechanisms. Data gaps were identified in Tokenomics and Security and Audit History (both scored -1.0 due to insufficient project-specific documentation and search name-collisions), and their weights were proportionally redistributed. No qualifying red-flag exploit or fraud was established, but the weak fundamentals justify an Avoid recommendation.
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About BiorLabs (BYB)
BYB is an ERC-20 token on the Ethereum blockchain associated with BiorLabs, a project formerly known as BiorBank. The project is focused on the crypto portfolio-management and dashboard niche, with product concepts including a portfolio-tracking dashboard and a tool referred to as BiorVault. The specific utility mechanisms of the BYB token within this product suite remain prospectively defined.
BiorLabs operates in an early-stage development posture. As of late 2025, communications indicated preparation for mainnet deployment with an emphasis on compliance; however, independently verifiable engineering outputs, codebase releases, and governance execution remain undocumented. Key tokenomics parameters—such as official supply allocations, vesting schedules, and emission models—are not formally documented on the primary platform resources.
The project carries significant risks related to liquidity, governance, and transparency. Market participation is minimal, characterized by near-zero daily trading volume, a holder base of approximately 607 addresses, and a low market capitalization. Additionally, the team behind BiorLabs is anonymous, with no named leadership or formalized decentralized governance structure, and the token lacks published third-party security audits.